Patents by Inventor Sylvie Gontier

Sylvie Gontier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer compound and pharmaceutical composition containing the same
    Patent number: 9221817
    Abstract: The invention relates to a compound of formula (I), more specifically in the levorotatory form (1a) thereof, in particular the form having a rotatory power [?]D=?38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound may be in the form of a base or an acid addition salt, in particular a pharmaceutically acceptable acid. The compound is a selective Aurora A and B kinase inhibitor and can be used as an anticancer drug.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: December 29, 2015
    Assignee: SANOFI
    Inventors: Jean-Christophe Carry, Michel Cheve, Francois Clerc, Cecile Combeau, Sylvie Gontier, Alain Krick, Sylvette Lachaud, Laurent Schio
  • ANTI-CANCER COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
    Publication number: 20150266877
    Abstract: The invention relates to a compound of formula (I), more specifically in the levorotatory form (1a) thereof, in particular the form having a rotatory power [?]D=?38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound may be in the form of a base or an acid addition salt, in particular a pharmaceutically acceptable acid. The compound is a selective Aurora A and B kinase inhibitor and can be used as an anticancer drug.
    Type: Application
    Filed: June 2, 2015
    Publication date: September 24, 2015
    Inventors: Jean-Christophe CARRY, Michel CHEVE, Francois CLERC, Cecile COMBEAU, Sylvie GONTIER, Alain KRICK, Sylvette LACHAUD, Laurent SCHIO
  • Anti-cancer compound and pharmaceutical composition containing the same
    Patent number: 9073917
    Abstract: The invention relates to a compound of formula (I), more specifically in the levorotatory form (1a) thereof, in particular the form having a rotatory power [?]D=?38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound may be in the form of a base or an acid addition salt, in particular a pharmaceutically acceptable acid. The compound is a selective Aurora A and B kinase inhibitor and can be used as an anticancer drug.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: July 7, 2015
    Assignee: SANOFI
    Inventors: Jean-Christophe Carry, Michel Cheve, Francois Clerc, Cecile Combeau, Sylvie Gontier, Alain Krick, Sylvette Lachaud, Laurent Schio
  • ANTI-CANCER COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
    Publication number: 20120220621
    Abstract: The invention relates to a compound of formula (I), more specifically in the levorotatory form (1a) thereof, in particular the form having a rotatory power [?]D=?38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound may be in the form of a base or an acid addition salt, in particular a pharmaceutically acceptable acid. The compound is a selective Aurora A and B kinase inhibitor and can be used as an anticancer drug.
    Type: Application
    Filed: May 17, 2010
    Publication date: August 30, 2012
    Applicant: SANOFI
    Inventors: Jean-Christophe Carry, Michel Cheve, Francois Clerc, Cecile Combeau, Sylvie Gontier, Alain Krick, Sylvette Lachaud, Laurent Schio
  • Chemical derivatives and their application as antitelomerase agents
    Publication number: 20030013711
    Abstract: The present invention relates to cancer therapies using novel anticancer agents with a specific mechanism of action. The invention also relates to novel chemical compounds and their therapeutic application in man.
    Type: Application
    Filed: February 22, 2002
    Publication date: January 16, 2003
    Inventors: Patrick Mailliet, Jean-Francois Riou, Abdelazize Laoui, Jean-Louis Mergny, Sylvie Gontier